Profile data is unavailable for this security.
About the company
Mithra Pharmaceuticals SA is a Belgian-based company active in the pharmaceutical industry. The Company is a biotech company providing solutions in a field of women’s health, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. The Company provides three development candidates built on Mithra’s estrogen platform, Estetrol (E4): Estelle, a solution for oral contraception, PeriNesta, the oral treatment targeting perimenopause and Donesta, a hormone therapy. The Company also develops and manufactures therapeutics in the areas of contraception, menopause and hormone-dependent cancers. It offers partners a spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. The Company operates in more than 100 countries around the world and is headquartered in Liege, Belgium.
- Revenue in EUR (TTM)40.16m
- Net income in EUR-173.50m
- Incorporated1999
- Employees229.00
- LocationMithra Pharmaceuticals SARue de l'Expansion 57FLEMALLE 4400BelgiumBEL
- Phone+32 43533700
- Fax+32 43492821
- Websitehttps://www.mithracdmo.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOGENED SA | 22.18m | 976.01k | 13.80m | 205.00 | 14.14 | -- | 7.69 | 0.622 | 1.71 | 1.71 | 38.90 | -- | -- | -- | -- | 466,145.20 | -- | 2.92 | -- | 4.13 | 66.42 | 68.04 | 4.40 | 3.31 | -- | 3.68 | -- | -- | 20.02 | 18.88 | 24.33 | 29.89 | 9.88 | -- |
| Abingdon Health PLC | 6.23m | -2.61m | 13.84m | 82.00 | -- | 6.54 | -- | 2.22 | -0.0184 | -0.0184 | 0.0439 | 0.0149 | 0.8978 | 7.67 | 4.74 | 65,170.73 | -37.55 | -51.31 | -58.04 | -79.85 | 57.35 | 33.16 | -41.82 | -139.64 | 1.59 | -- | 0.3572 | -- | 42.68 | -- | 83.77 | -- | -- | -- |
| Arterra Bioscience SpA | 3.30m | 1.08m | 13.98m | 30.00 | 12.94 | 1.29 | 8.24 | 4.23 | 0.1624 | 0.1624 | 0.4985 | 1.62 | 0.263 | 1.18 | -- | -- | 8.57 | 10.57 | 9.44 | 12.30 | 55.03 | 60.57 | 32.57 | 34.31 | 7.47 | -- | -- | -- | -7.28 | 6.36 | -23.89 | 0.6056 | -- | -- |
| Vivesto AB | 0.00 | -11.05m | 14.09m | 14.00 | -- | 0.8297 | -- | -- | -0.2414 | -0.2414 | 0.00 | 0.3676 | 0.00 | -- | -- | 0.00 | -44.66 | -- | -48.73 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -100.00 | -- | 64.80 | -- | -- | -- |
| Shield Therapeutics PLC | 8.41m | -54.70m | 14.14m | 28.00 | -- | 0.4078 | -- | 1.68 | -0.1549 | -0.1549 | 0.0151 | 0.038 | 0.1691 | 1.80 | 0.9805 | -- | -109.95 | -42.77 | -129.39 | -48.12 | 44.76 | 79.44 | -650.12 | -274.35 | 2.64 | -124.94 | 0.1756 | -- | 261.55 | 53.86 | -151.04 | -- | -7.68 | -- |
| Addex Therapeutics Ltd | 1.69m | -10.82m | 14.17m | 23.00 | -- | 8.20 | -- | 8.39 | -0.1433 | -0.1433 | 0.0222 | 0.0092 | 0.2549 | -- | 14.82 | 71,612.17 | -163.36 | -69.05 | -312.84 | -84.19 | -- | -- | -640.91 | -572.59 | -- | -34.12 | 0.2311 | -- | 13.99 | -24.47 | 49.26 | -- | -5.45 | -- |
| AlzeCure Pharma AB | 0.00 | -3.21m | 14.19m | 11.00 | -- | 8.36 | -- | -- | -0.5685 | -0.5685 | 0.00 | 0.2122 | 0.00 | -- | -- | 0.00 | -92.80 | -52.78 | -115.25 | -57.01 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 33.91 | -- | -- | -- |
| Mithra Pharmaceuticals SA | 40.16m | -173.50m | 14.45m | 229.00 | -- | -- | -- | 0.3599 | -2.51 | -2.51 | 0.6363 | -1.49 | 0.1102 | 0.4452 | 0.777 | -- | -47.60 | -22.24 | -70.17 | -27.69 | 45.34 | 73.13 | -432.08 | -199.11 | 0.4339 | -3.07 | 2.01 | -- | -40.06 | -7.05 | -191.01 | -- | -- | -- |
| Synairgen plc | 0.00 | -11.65m | 14.56m | 30.00 | -- | 0.7821 | -- | -- | -0.0496 | -0.0496 | 0.00 | 0.0793 | 0.00 | -- | -- | 0.00 | -41.40 | -54.75 | -48.86 | -60.72 | -- | -- | -- | -83,247.62 | -- | -- | 0.00 | -- | -- | -- | 63.74 | -- | 0.00 | -- |
| Ikonisys SA | 538.56k | -2.40m | 14.74m | 11.00 | -- | 0.8063 | -- | 27.36 | -0.2499 | -0.2499 | 0.056 | 1.75 | 0.0246 | 1.14 | 6.20 | 48,960.00 | -10.94 | -- | -12.55 | -- | 2.72 | -- | -444.76 | -- | 0.0818 | -36.79 | 0.1007 | -- | 68.94 | -- | -328.57 | -- | -- | -- |
| Read Gene SA | 2.33m | -428.66k | 14.78m | 11.00 | -- | 14.43 | -- | 6.33 | -0.1954 | -0.1954 | 1.06 | 0.3741 | 0.666 | 48.81 | 4.51 | -- | -12.24 | -1.71 | -13.14 | -2.11 | 88.57 | 88.01 | -18.37 | -3.90 | 6.46 | -4.19 | -- | -- | 38.79 | 15.77 | -966.00 | -- | -- | -- |
| PMD Device Solutions AB | 2.46m | -3.11m | 15.03m | 1.00 | -- | -- | -- | 6.12 | -16.69 | -16.69 | 6.34 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 58.18 | -- | -126.39 | -- | -- | -3.00 | -- | -- | -- | -- | -- | -- | -- | -- |
| Incanthera PLC | 0.00 | -1.72m | 15.06m | 8.00 | -- | -- | -- | -- | -0.0192 | -0.0192 | 0.00 | -0.0086 | 0.00 | -- | -- | 0.00 | -373.20 | -101.74 | -- | -132.88 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -36.11 | -- | -- | -- |
| Kancera AB | 0.00 | -5.57m | 15.09m | 3.00 | -- | -- | -- | -- | -0.786 | -0.786 | 0.00 | -- | -- | -- | -- | 0.00 | -- | -54.82 | -- | -66.21 | -- | -- | -- | -7,249.06 | -- | -- | -- | -- | -- | -- | -23.64 | -- | -- | -- |
| Diod PAO | 5.58m | 78.12k | 15.22m | -- | 194.90 | 1.32 | 51.64 | 2.73 | 0.0839 | 0.0839 | 6.00 | 12.37 | 0.3971 | 0.7696 | 1.84 | -- | 0.6091 | 3.38 | 0.6674 | 3.71 | 51.98 | 56.53 | 1.53 | 8.29 | 4.22 | -- | 0.0461 | -- | -2.21 | -6.65 | -80.99 | -6.90 | 17.47 | -- |
Data as of Apr 26 2024. Currency figures normalised to Mithra Pharmaceuticals SA's reporting currency: Euro EUR
0.69%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BNP Paribas Asset Management Belgium SAas of 29 Feb 2024 | 359.75k | 0.52% |
| BNP Paribas Asset Management Europe SASas of 29 Nov 2023 | 111.92k | 0.16% |
| BlackRock Investment Management (UK) Ltd.as of 31 Jul 2023 | 2.47k | 0.00% |
| Dimensional Fund Advisors Ltd.as of 29 Feb 2024 | 2.26k | 0.00% |
| Dimensional Fund Advisors LPas of 31 Jan 2024 | 925.00 | 0.00% |
| SSgA Funds Management, Inc.as of 04 Apr 2024 | 516.00 | 0.00% |
| CAPFI DELEN Asset Management NVas of 31 Mar 2023 | 0.00 | 0.00% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 0.00 | 0.00% |
| Irish Life Investment Managers Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
| Northern Trust Global Investments Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 02 May 2024Source: FactSet Research Systems Inc.
